Nanomedicine Market (2021-2026): Global Key Competitors Include Abbott Laboratories, Luminex Corporation, Merck & Co, Nanobiotix and Novartis
Dublin, Dec. 29, 2021 (GLOBE NEWSWIRE) -- The "Nanomedicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
The global nanomedicine market exhibited strong growth during 2015-2020. Looking forward, the market is expected to grow at a CAGR of around 10% during 2021-2026.
Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.
Nanomedicine refers to specialized multi-functional drugs with programmable properties used for the treatment of diseases and repairing tissues at a molecular level.
It involves the use of nanoparticles, nanotubes and nanodevices, such as imaging agents, nanorobots, biochips and polymer therapeutics, for the diagnosis, treatment and prevention of a disorder and analyzing the underlying pathophysiology. The nanoparticles include metal and metal oxides, liposomes and inorganic particles, which are used for transporting the drugs and targeting difficult to reach areas in the body.
As a result, nanomedicine finds extensive applications for drug delivery, diagnostic imaging, vaccines, regenerative medicines and implants.
Nanomedicine Market Trends:
The increasing prevalence of chronic medical ailments across the globe is one of the key factors creating a positive outlook for the market. Nanomedicine is highly beneficial in the treatment of oncological, neurological, urological, infectious, ophthalmological, orthopedic, immunological and cardiovascular diseases.
Moreover, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for nanomedicines to produce vaccines and nanocarrier systems with enhanced efficacies. In line with this, shifting preference for personalized medicines is also contributing to the growth of the market.
Additionally, various technological advancements in the nanoscale technologies for improved diagnostic procedures are acting as other growth-inducing factors. Pharmaceutical manufacturers are using nanorobotic systems and other novel solutions for the effective administration of nanomedicines. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are anticipated to drive the market toward growth.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global nanomedicine market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, nanomolecule type, product and application.
Breakup by Nanomolecule Type:
Metal and Metal Oxide Nanoparticles
Polymers and Polymer Drug Conjugates
Hydrogel Nanoparticles
Dendrimers
Inorganic Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Breakup by Product:
In-Vivo diagnostics
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being:
Arrowhead Pharmaceuticals Inc.
General Electric Company
Luminex Corporation
Nanobiotix
Sanofi SA
Starpharma Holdings Limited.
Key Questions Answered in This Report:
How has the global nanomedicine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global nanomedicine market?
What are the key regional markets?
What is the breakup of the market based on the nanomolecule type?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global nanomedicine market and who are the key players?
What is the degree of competition in the industry?
For more information about this report visit https://www.researchandmarkets.com/r/qqprz8
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Unilever pursues GSK-Pfizer unit after huge bid rebuffed
Consumer goods giant Unilever on Monday said it would press on with a bid for the consumer health care unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer after an offer of £50 billion ($68 billion) was refused.
2 cheap FTSE 100 stocks to buy!
I'm searching for the best low-cost FTSE 100 stocks to buy. Here are two I think could be too cheap for me to miss right now. The post 2 cheap FTSE 100 stocks to buy! appeared first on The Motley Fool UK.
Hydrogen company lines up £50m Aim float
A Doncaster-based maker of equipment to produce hydrogen will join the stock market to capitalise on booming demand for the clean-burning gas.